Search research articles
Contact Us
Filters
Showing results (11-20 of 26) with videos related to
Page
of 3
Sort By:
Cancer & Metabolism
|
September 27, 2021
Robust metabolic transcriptional components in 34,494 patient-derived cancer-related samples and cell lines
V C Leeuwenburgh, C G Urzúa-Traslaviña, A Bhattacharya, et al.
Scandinavian Journal of Gastroenterology
|
October 9, 2003
Dysplasia in fundic gland polyps is associated with nuclear beta-catenin expression and relatively high cell turnover rates
M Jalving, J J Koornstra, W Boersma-van Ek, et al.
The Journal of Dermatology
|
December 11, 2023
Systemic therapy timing and use in patients with advanced melanoma at the end of life: A retrospective cohort study
P E A van Lith, K Schreuder, M Jalving, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education
|
February 1, 2021
The Summer School Oncology Groningen: Improving a Successful International Course by Refining the Old, Maintaining What's Good
E C E Boske, P H Nienhuis, C Hammer, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation
|
January 21, 2022
Immune checkpoint inhibitor-associated myocarditis : Case reports and a review of the literature
T E Osinga, S F Oosting, P van der Meer, et al.
Carcinogenesis
|
January 1, 2014
Regulation of TRAIL receptor expression by β-catenin in colorectal tumours
M Jalving, D M Heijink, J J Koornstra, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 4, 2016
Molecular imaging in ovarian cancer
A K L Reyners, K E Broekman, A W J M Glaudemans, et al.
Cancer Immunology, Immunotherapy : CII
|
September 10, 2025
Upfront whole blood transcriptional patterns in patients receiving immune checkpoint inhibitors associate with clinical outcome
S Hone Lopez, S Loipfinger, A Bhattacharya, et al.
Pharmacology & Therapeutics
|
December 3, 2014
Targeting breast cancer through its microenvironment: current status of preclinical and clinical research in finding relevant targets
H H Nienhuis, S B M Gaykema, H Timmer-Bosscha, et al.
ESMO Open
|
February 15, 2025
Adjuvant immunotherapy in the modern management of resectable melanoma: current status and outlook to 2028
M Donia, H Jespersen, M Jalving, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 26) with videos related to
Sort By:
Page
of 3
Cancer & Metabolism
|
September 27, 2021
Robust metabolic transcriptional components in 34,494 patient-derived cancer-related samples and cell lines
V C Leeuwenburgh, C G Urzúa-Traslaviña, A Bhattacharya, et al.
Scandinavian Journal of Gastroenterology
|
October 9, 2003
Dysplasia in fundic gland polyps is associated with nuclear beta-catenin expression and relatively high cell turnover rates
M Jalving, J J Koornstra, W Boersma-van Ek, et al.
The Journal of Dermatology
|
December 11, 2023
Systemic therapy timing and use in patients with advanced melanoma at the end of life: A retrospective cohort study
P E A van Lith, K Schreuder, M Jalving, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education
|
February 1, 2021
The Summer School Oncology Groningen: Improving a Successful International Course by Refining the Old, Maintaining What's Good
E C E Boske, P H Nienhuis, C Hammer, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation
|
January 21, 2022
Immune checkpoint inhibitor-associated myocarditis : Case reports and a review of the literature
T E Osinga, S F Oosting, P van der Meer, et al.
Carcinogenesis
|
January 1, 2014
Regulation of TRAIL receptor expression by β-catenin in colorectal tumours
M Jalving, D M Heijink, J J Koornstra, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 4, 2016
Molecular imaging in ovarian cancer
A K L Reyners, K E Broekman, A W J M Glaudemans, et al.
Cancer Immunology, Immunotherapy : CII
|
September 10, 2025
Upfront whole blood transcriptional patterns in patients receiving immune checkpoint inhibitors associate with clinical outcome
S Hone Lopez, S Loipfinger, A Bhattacharya, et al.
Pharmacology & Therapeutics
|
December 3, 2014
Targeting breast cancer through its microenvironment: current status of preclinical and clinical research in finding relevant targets
H H Nienhuis, S B M Gaykema, H Timmer-Bosscha, et al.
ESMO Open
|
February 15, 2025
Adjuvant immunotherapy in the modern management of resectable melanoma: current status and outlook to 2028
M Donia, H Jespersen, M Jalving, et al.
Page
of 3